BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8977316)

  • 1. Inducible nuclear factors binding the IgM heavy chain pre-mRNA secretory poly(A) site.
    Phillips C; Schimpl A; Dietrich-Goetz W; Clements JB; Virtanen A
    Eur J Immunol; 1996 Dec; 26(12):3144-52. PubMed ID: 8977316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The binding of a subunit of the general polyadenylation factor cleavage-polyadenylation specificity factor (CPSF) to polyadenylation sites changes during B cell development.
    Edwalds-Gilbert G; Milcarek C
    Nucleic Acids Symp Ser; 1995; (33):229-33. PubMed ID: 8643379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in vivo generation of murine IgD-secreting cells is accompanied by deletion of the C mu gene and occasional deletion of the gene for the C delta 1 domain.
    Mountz JD; Mushinski JF; Owens JD; Finkelman FD
    J Immunol; 1990 Sep; 145(5):1583-91. PubMed ID: 1696602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional activation of the alpha1(I) procollagen gene and up-regulation of alpha1(I) and alpha1(III) procollagen messenger RNA in dermal fibroblasts from tight skin 2 mice.
    Christner PJ; Hitraya EG; Peters J; McGrath R; Jiménez SA
    Arthritis Rheum; 1998 Dec; 41(12):2132-42. PubMed ID: 9870870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated levels of the polyadenylation factor CstF 64 enhance formation of the 1kB Testis brain RNA-binding protein (TB-RBP) mRNA in male germ cells.
    Chennathukuzhi VM; Lefrancois S; Morales CR; Syed V; Hecht NB
    Mol Reprod Dev; 2001 Apr; 58(4):460-9. PubMed ID: 11241784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developmental regulation of membrane and secretory Ig gamma 2b mRNA.
    Brown SL; Morrison SL
    J Immunol; 1989 Mar; 142(6):2072-80. PubMed ID: 2921524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An NFAT-dependent enhancer is necessary for anti-IgM-mediated induction of murine CD5 expression in primary splenic B cells.
    Berland R; Wortis HH
    J Immunol; 1998 Jul; 161(1):277-85. PubMed ID: 9647234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective antigen-receptor-mediated regulation of immunoglobulin production in B cells from autoimmune strains of mice.
    Anderson CC; Cairns E; Rudofsky UH; Sinclair NR
    Cell Immunol; 1995 Aug; 164(1):141-9. PubMed ID: 7634346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of IgM and IgD expression in human B-lineage cells.
    Kerr WG; Hendershot LM; Burrows PD
    J Immunol; 1991 May; 146(10):3314-21. PubMed ID: 1902853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative expression of secreted and membrane forms of immunoglobulin mu-chain is regulated by transcriptional termination in stable plasmacytoma transfectants.
    Guise JW; Lim PL; Yuan D; Tucker PW
    J Immunol; 1988 Jun; 140(11):3988-94. PubMed ID: 3131424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of transcripts derived from promoter III of the acetyl-CoA carboxylase-alpha gene in mammary gland is associated with recruitment of SREBP-1 to a region of the proximal promoter defined by a DNase I hypersensitive site.
    Barber MC; Vallance AJ; Kennedy HT; Travers MT
    Biochem J; 2003 Oct; 375(Pt 2):489-501. PubMed ID: 12871210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of transcriptional termination in the regulation of mu mRNA expression in B lymphocytes.
    Weiss EA; Michael A; Yuan D
    J Immunol; 1989 Aug; 143(3):1046-52. PubMed ID: 2501386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of immunoglobulin gene expression in normal lymphocytes. II. Mechanisms of down-regulation of immunoglobulin secretion after engagement of the B cell antigen receptor.
    Berberich I; Schimpl A
    Eur J Immunol; 1992 Feb; 22(2):525-9. PubMed ID: 1537386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple features contribute to the use of the immunoglobulin M secretion-specific poly(A) signal but are not required for developmental regulation.
    Peterson ML; Bingham GL; Cowan C
    Mol Cell Biol; 2006 Sep; 26(18):6762-71. PubMed ID: 16943419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of polyadenylation in health and disease.
    Curinha A; Oliveira Braz S; Pereira-Castro I; Cruz A; Moreira A
    Nucleus; 2014; 5(6):508-19. PubMed ID: 25484187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. U1A inhibits cleavage at the immunoglobulin M heavy-chain secretory poly(A) site by binding between the two downstream GU-rich regions.
    Phillips C; Pachikara N; Gunderson SI
    Mol Cell Biol; 2004 Jul; 24(14):6162-71. PubMed ID: 15226420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The regulated production of mu m and mu s mRNA is dependent on the relative efficiencies of mu s poly(A) site usage and the c mu 4-to-M1 splice.
    Peterson ML; Perry RP
    Mol Cell Biol; 1989 Feb; 9(2):726-38. PubMed ID: 2565533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of nuclear poly(A) addition controls the expression of immunoglobulin M secretory mRNA.
    Phillips C; Jung S; Gunderson SI
    EMBO J; 2001 Nov; 20(22):6443-52. PubMed ID: 11707415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence elements upstream of the 3' cleavage site confer substrate strength to the adenovirus L1 and L3 polyadenylation sites.
    Prescott J; Falck-Pedersen E
    Mol Cell Biol; 1994 Jul; 14(7):4682-93. PubMed ID: 7911973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of differential processing of mouse immunoglobulin mu heavy-chain mRNA.
    Tsurushita N; Avdalovic NM; Korn LJ
    Nucleic Acids Res; 1987 Jun; 15(11):4603-15. PubMed ID: 3108856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.